MX2022010020A - Empleo del compuesto en la prevencion y/o el tratamiento de infecciones patogenas en animales. - Google Patents

Empleo del compuesto en la prevencion y/o el tratamiento de infecciones patogenas en animales.

Info

Publication number
MX2022010020A
MX2022010020A MX2022010020A MX2022010020A MX2022010020A MX 2022010020 A MX2022010020 A MX 2022010020A MX 2022010020 A MX2022010020 A MX 2022010020A MX 2022010020 A MX2022010020 A MX 2022010020A MX 2022010020 A MX2022010020 A MX 2022010020A
Authority
MX
Mexico
Prior art keywords
compound
animals
prevention
treatment
pathogen infection
Prior art date
Application number
MX2022010020A
Other languages
English (en)
Inventor
Xingyu Lin
Di Kang
Tingting Lu
Danni Li
Original Assignee
Felicamed Biotechnology Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Felicamed Biotechnology Co Ltd filed Critical Felicamed Biotechnology Co Ltd
Publication of MX2022010020A publication Critical patent/MX2022010020A/es

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/4427—Non condensed pyridines; Hydrogenated derivatives thereof containing further heterocyclic ring systems
    • A61K31/444—Non condensed pyridines; Hydrogenated derivatives thereof containing further heterocyclic ring systems containing a six-membered ring with nitrogen as a ring heteroatom, e.g. amrinone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/445—Non condensed piperidines, e.g. piperocaine
    • A61K31/4523—Non condensed piperidines, e.g. piperocaine containing further heterocyclic ring systems
    • A61K31/4545—Non condensed piperidines, e.g. piperocaine containing further heterocyclic ring systems containing a six-membered ring with nitrogen as a ring hetero atom, e.g. pipamperone, anabasine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/425—Thiazoles
    • A61K31/427—Thiazoles not condensed and containing further heterocyclic rings
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/10—Antimycotics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/14—Antivirals for RNA viruses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P33/00—Antiparasitic agents
    • A61P33/02—Antiprotozoals, e.g. for leishmaniasis, trichomoniasis, toxoplasmosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P33/00—Antiparasitic agents
    • A61P33/10—Anthelmintics

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Organic Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Virology (AREA)
  • Epidemiology (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Molecular Biology (AREA)
  • Mycology (AREA)
  • Nutrition Science (AREA)
  • Engineering & Computer Science (AREA)
  • Food Science & Technology (AREA)
  • Polymers & Plastics (AREA)
  • Dermatology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Fodder In General (AREA)
  • Coloring Foods And Improving Nutritive Qualities (AREA)

Abstract

La presente invención da a conocer la aplicación de un compuesto para prevenir y/o tratar la infección patógena en los animales. Se trata del compuesto 4-(3-{2-amino-5-[2-(1-methyl-piperidin-4-yl )-thiazol-5-yl]-pyridin-3-yloxymethyl}-phenyl)-2-methylbut-3-yn-2 -ol el cual tiene la estructura de la fórmula I que aparece a continuación. El compuesto puede utilizarse para tratar de forma eficaz las enfermedades (por ejemplo, la peritonitis infecciosa felina) provocadas por la infección de patógenos animales (especialmente los virus, como los coronavirus), y para aumentar la supervivencia de los animales, y puede tener un mayor valor comercial y perspectivas de aplicación en el ámbito de los medicamentos veterinarios contra los patógenos (especialmente los virus, como los coronavirus).
MX2022010020A 2020-06-16 2021-06-11 Empleo del compuesto en la prevencion y/o el tratamiento de infecciones patogenas en animales. MX2022010020A (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
CN202010547186.8A CN113797198B (zh) 2020-06-16 2020-06-16 一种化合物在预防和/或治疗动物的病原体感染中的应用
PCT/CN2021/099650 WO2021254265A1 (zh) 2020-06-16 2021-06-11 一种化合物在预防和/或治疗动物的病原体感染中的应用

Publications (1)

Publication Number Publication Date
MX2022010020A true MX2022010020A (es) 2022-10-10

Family

ID=78892522

Family Applications (1)

Application Number Title Priority Date Filing Date
MX2022010020A MX2022010020A (es) 2020-06-16 2021-06-11 Empleo del compuesto en la prevencion y/o el tratamiento de infecciones patogenas en animales.

Country Status (12)

Country Link
US (1) US20230097009A1 (es)
EP (1) EP4094763A4 (es)
JP (1) JP7442662B2 (es)
KR (1) KR20220129592A (es)
CN (2) CN117338775A (es)
AU (1) AU2021291983B2 (es)
BR (1) BR112022016727A2 (es)
CA (1) CA3168377A1 (es)
CO (1) CO2022011666A2 (es)
MX (1) MX2022010020A (es)
WO (1) WO2021254265A1 (es)
ZA (1) ZA202213500B (es)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN114839378B (zh) * 2022-07-04 2022-09-06 山东康华生物医疗科技股份有限公司 一种猫疱疹和猫杯状病毒联合检测试剂盒
CN114966020B (zh) * 2022-07-13 2022-09-27 北京市农林科学院 检测牛传染性鼻气管炎病毒的胶体金试纸条及其制备方法

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US11166959B2 (en) * 2017-11-06 2021-11-09 Bristol-Myers Squibb Company Isofuranone compounds useful as HPK1 inhibitors
CN110372664A (zh) * 2018-04-13 2019-10-25 华东理工大学 选择性jak2抑制剂及其应用
CN110396087A (zh) * 2018-04-25 2019-11-01 珠海宇繁生物科技有限责任公司 Hpk1激酶抑制剂、制备方法及其应用
WO2019206049A1 (en) * 2018-04-25 2019-10-31 Zhuhai Yufan Biotechnologies Co., Ltd Hpk1 inhibitors, preparation method and application thereof
CN110063954B (zh) * 2019-04-10 2021-08-06 华中农业大学 Fhpi在制备治疗猫传染性腹膜炎药物中的应用
CN110215456A (zh) * 2019-06-25 2019-09-10 华中农业大学 一种由gc376与gs-441524组成的猫冠状病毒抑制剂组合物
MX2022016344A (es) * 2020-06-16 2023-01-24 Zhuhai Yufan Biotechnologies Co Ltd Aplicacion de un inhibidor de la quinasa hpk1 en la prevencion y/o el tratamiento de las infecciones por patogenos animales.

Also Published As

Publication number Publication date
AU2021291983A1 (en) 2022-09-08
CN113797198A (zh) 2021-12-17
CN117338775A (zh) 2024-01-05
ZA202213500B (en) 2023-07-26
JP2023525430A (ja) 2023-06-16
EP4094763A4 (en) 2023-04-26
JP7442662B2 (ja) 2024-03-04
CO2022011666A2 (es) 2022-08-30
BR112022016727A2 (pt) 2022-12-27
CA3168377A1 (en) 2021-12-23
WO2021254265A1 (zh) 2021-12-23
US20230097009A1 (en) 2023-03-30
KR20220129592A (ko) 2022-09-23
CN113797198B (zh) 2023-11-28
AU2021291983B2 (en) 2024-01-18
EP4094763A1 (en) 2022-11-30

Similar Documents

Publication Publication Date Title
MX2022010020A (es) Empleo del compuesto en la prevencion y/o el tratamiento de infecciones patogenas en animales.
MX2022012714A (es) Inhibidores de la replicacion de norovirus y coronavirus.
ZA202213687B (en) Use of hpk1 kinase inhibitor in preventing and/or treating pathogen infection in animals
BRPI0618374A2 (pt) uso de um composto ou um derivado do mesmo farmaceuticamente aceitável, métodos para matar microorganismos clinicamente latentes em um mamìfero, para tratar ou prevenir uma infecção microbiana em um mamìfero, para esterilizar um objeto, para preservar um material inorgánico ou orgánico, para tratar uma doença, para reduzir a dose de agente antimicrobiano convencional requerida para tratar uma infecção microbiana e para tratar uma doença de protozoário em um mamìfero, produto combinado, formulação, uso de um produto combinado, composto, e, processo para a preparação do mesmo
MX2009012390A (es) Uso de compuestos de 4-(pirrolidin-1-il)quinolina para exterminar microorganismos clinicamente latentes.
MX2015009225A (es) Compuestos tetraciclicos sustituidos con heterociclo y metodos de uso de los mismos para el tratamiento de enfermedades viricas.
NZ607580A (en) N-heteroaryl compounds
MX2022011173A (es) Tratamiento de infeccion por coronavirus.
MX2023009052A (es) Compuesto de bifenilo como inmunomodulador, método de preparación para el mismo y uso del mismo.
CN104824042A (zh) 一种抑菌型猪舍消毒液
PH12015502128A1 (en) Novel dosing regimens of celgosivir for the treatment of dengue
CN104940191B (zh) 一种脂溶性没食子儿茶素没食子酸棕榈酸酯消毒剂及制备方法
BR9915639A (pt) Uso de derivados de ácido fosfonofórmico para o tratamento de infecções
CN101690836A (zh) 氧气湿化液
CN114748466A (zh) Napyradiomycin类化合物在制备猪伪狂犬病病毒抑制剂中的应用
ATE522217T1 (de) Zusammensetzungen zur behandlung, reduktion, verminderung oder verhinderung von infektionen des ohrs oder der oberen atemwege
MX2009006311A (es) Terapia de combinacion para tratar infecciones de hepatitis c.
MD3674G2 (ro) Metodă de profilaxie şi tratament al ectoparazitozelor la găini
WO2009002922A3 (en) Single dose roxithromycin
CA3242451A1 (en) An injectable pharmaceutical composition for the treatment of respiratory diseases in animals
RU2562585C1 (ru) Способ повышения биоцидной и лечебной эффективности стафилококковой анатоксин-вакцины
AR128074A1 (es) Composición farmacéutica inyectable para el tratamiento de enfermedades respiratorias en animales
EA201892278A1 (ru) Анбитактериальные биароматические производные с оксетан-3-илокси замещением
MD92Z (ro) Metodă de tratament al ectoparazitozei la găini
CN114805278A (zh) Napyradiomycin A4及其在抗猪伪狂犬病病毒中的应用